PA
ELV icon

Paralel Advisors’s Elevance Health ELV Stock Holding History

Paralel Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
7,891
+1,741
+28% +$646K 0.12% 42
2026
Q1 		$1.8M Hold
6,150
– – 0.07% 84
2025
Q4 		$2.16M Hold
6,150
– – 0.08% 77
2025
Q3 		$1.99M Buy
6,150
+7
+0.1% +$2.18K 0.08% 85
2025
Q2 		$2.39M Buy
6,143
+1,300
+27% +$523K 0.1% 80
2025
Q1 		$2.11M Hold
4,843
– – 0.09% 77
2024
Q4 		$1.79M Buy
4,843
+440
+10% +$184K 0.08% 91
2024
Q3 		$2.29M Hold
4,403
– – 0.1% 67
2024
Q2 		$2.39M Buy
4,403
+243
+6% +$128K 0.11% 39
2024
Q1 		$2.16M Hold
4,160
– – 0.1% 65
2023
Q4 		$1.96M Hold
4,160
– – 0.1% 71
2023
Q3 		$1.81M Buy
4,160
+47
+1% +$21.3K 0.1% 59
2023
Q2 		$1.83M Buy
4,113
+461
+13% +$213K 0.1% 67
2023
Q1 		$1.68M Buy
3,652
+96
+3% +$45.7K 0.09% 58
2022
Q4 		$1.82M Buy
+3,556
New +$1.81M 0.11% 44

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paralel Advisors's ELV Position: Q2 2026 in Review

Paralel Advisors increased its Elevance Health (ELV) stake by 28% in Q2 2026, buying an estimated $646K and bringing the position to 7,891 shares worth $3.05M. The position accounts for 0.12% of the portfolio, ranked #42.

Paralel Advisors first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Paralel Advisors held 7,891 shares of Elevance Health worth $3.05M as of Q2 2026.
  • Paralel Advisors bought 1,741 Elevance Health shares in Q2 2026, an estimated $646K.
  • Elevance Health made up 0.12% of Paralel Advisors's portfolio in Q2 2026, its #42 holding.
  • Paralel Advisors first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Paralel Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.